Palisade Bio Inc. Watch

from 8-K 36 pages 158,000 Shares of Common Stock, 3,120,688 Pre-Funded Warrants to Purchase Up to 3,120,688 Shares of Common Stock and 3,278,688 Common Warrants to Purchase Up to 3,278,688 Shares of Common Stock of Palisade Bio, Inc. Underwriting Agreement

from S-1/A 42 pages [ ] Shares of Common Stock, [ ] Pre-Funded Warrants to Purchase Up to [ ] Shares of Common Stock and [ ] Common Warrants to Purchase Up to [ ] Shares of Common Stock of Palisade Bio, Inc. Underwriting Agreement

from S-1/A 42 pages [ ] Shares of Common Stock and [ ] Warrants to Purchase Up to [ ] Shares of Common Stock of Palisade Bio, Inc. Underwriting Agreement

from SC 13G/A ~5 pages Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1

from 8-K 45 pages 42,160,000 Shares of Common Stock, 1,460 Shares of Series B Convertible Preferred Stock (Convertible Into 5,840,000 Shares of Common Stock) 48,000,000 Series 1 Warrants (Exercisable for 48,000,000 Shares of Common Stock) and 48,000,000 Series 2 Warrants (Exercisable for 48,000,000 Shares of Common Stock) of Palisade Bio, Inc. Underwriting Agreement

from S-1/A 45 pages Shares of Common Stock, Shares of Series B Convertible Preferred Stock (Convertible Into Shares of Common Stock) Series 1 Warrants (Exercisable for Shares of Common Stock) and Series 2 Warrants (Exercisable for Shares of Common Stock) of Palisade Bio, Inc. Underwriting Agreement

from S-1/A 45 pages Shares of Common Stock, Shares of Series B Convertible Preferred Stock (Convertible Into Shares of Common Stock) Series 1 Warrants (Exercisable for Shares of Common Stock) and Series 2 Warrants (Exercisable for Shares of Common Stock) of Palisade Bio, Inc. Underwriting Agreement

from S-1/A 44 pages Shares of Common Stock, Shares of Series B Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants (Exercisable for Shares of Common Stock) of Palisade Bio, Inc. Underwriting Agreement

from SC 13G/A 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1

from S-1/A 42 pages Shares of Common Stock, Series M Warrants (Exercisable for Shares), Series N Warrants (Exercisable for Shares) and Series O Prefunded Warrants (Exercisable for Shares) of Neuralstem, Inc. Underwriting Agreement

from 8-K 42 pages 3,000,000 Shares of Common Stock and Warrants to Purchase 2,250,000 Shares of Common Stock Neuralstem, Inc. Underwriting Agreement

from 8-K 36 pages 20,000,000 Shares of Common Stock and Warrants to Purchase 20,000,000 Shares of Common Stock Neuralstem, Inc. Underwriting Agreement

from 8-K 3 pages Underwriting agreement

from 8-K 3 pages Underwriting agreement

from 8-K 43 pages Placement Agency Agreement

from 8-K 39 pages $2,400,000 in Shares of Common Stock Neuralstem, Inc. Underwriting Agreement

from 8-K 3 pages A. the Company Will Enter Into a Securities Purchase Agreement (The “Purchase Agreement”) With the Purchasers to Be Identified on the Signature Pages of the Purchase Agreement (Collectively, the “Investors”) in Connection With the Placement of Common Stock of the Company in the Aggregate Amount of $ (The “Common Stock”) and Warrants to Purchase an Amount of Shares of Common Stock of the Company Equal to One Hundred Percent (100%) of the Number of Shares That the Investors Would Own on the Initial Closing Date (The "Investor Warrants"); B. the Broker Is a Licensed Broker-Dealer With the National Association of Securities Dealers; C. the Broker Introduced the Company to the Investors and Assisted the Company in the Transactions Contemplated by the Purchase Agreement; D. if the Company Closes the Transaction Contemplated Herein, the Company Wishes to Reward the Broker for Its Services in the Manner Hereinafter Set Forth. Now, Therefore, in Consideration of the Mutual Covenants, Promises, Conditions, Warranties and Representations Hereinafter Set Forth, the Parties Hereto Agree as Follows

from 8-K 21 pages Neuralstem, Inc. Common Stock ($0.01 Par Value Per Share) At-The-Market Equity Offering Sales Agreement

from 8-K 2 pages Amendment to Engagement Agreement

from 8-K 11 pages Confidential